Keytruda 100MG/4ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTDZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,790
Award facts
- Contract value 100% obligated
- $41,789.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $41,789.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Keytruda 100mg/4ml. The award was issued on December 8, 2025, with an ultimate completion date of December 11, 2025. DMS Pharmaceutical Group, which has been registered in the System for Award Management since 2001, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order will be performed in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a ceiling value of $499.999 billion and an ultimate completion date of December 31, 2036. The PPV-G GEN V represents part of a broader $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply comprehensive pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FBTDZ?
SPE2DR26FBTDZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FBTDZ worth?
The government has obligated $41,790 on SPE2DR26FBTDZ.
Is contract SPE2DR26FBTDZ an order under another contract?
Yes. SPE2DR26FBTDZ is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTDZ competed?
The extent of competition for SPE2DR26FBTDZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award